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This is a retrospective, observational descriptive study of a case series of evaluated results of patch tests of 1406 patients who had suspected allergic contact dermatitis from July 1 st ,2003 to June 30 th , 2010. All the results of patch tests performed since the beginning of the activities of this ambulatory were included in this study. The 12 most frequent allergens of the Brazilian Standard Series were nickel sulfate, thimerosal, potassium dichromate, p-phenylenediamine, cobalt chloride, fragrance mix, neomycin, Myroxylon pereirae, formaldehyde, ethylenediamine, PPD mix, carba mix and the least frequent allergens were lanolin and paratertiary butylphenol (Table1). The most frequent allergen of the Cosmetic Screening was tosylamide formaldehyde resin (10.4%) ( Table 2) .
89.8% of the positive patch-test results were considered relevant. Allergic contact dermatitis was GBEDC data, 1995 GBEDC data, -1996 , there is similarity about the age group, predominance in females (69.7% versus 62.5% in GBEDC study) and the rate of "at least one positive test": 62.8% versus 62.0% in the GBEDC study. Regarding the 12 most frequent allergens of both studies, nine allergens are common. Six substances ranked differently: quaternium 15 (11.2%) was placed in the third position in the GBEDC study but just in the 18th in our study (1.4%); quinoline mix and thiuram mix are also among the 12 most frequent allergens of the GBEDC study but not in this study; Myroxylon pereirae, ethylenediamine and PPD mix are among the 12 most frequent allergens of this study but not in the GBEDC study.
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Nickel was the most frequent allergen in both studies. The nickel rates were: 31.4% (442 patients) in this study and 25.1% in the other. Thimerosal was the second most frequent allergen in both studies: 14.7% (207) in our study and 16.3% in the GBEDC study. Potassium dichromate that was the third most frequent allergen in this study and the seventh in the other, but with the same rate (8.1%).
2 The rate differences between these studies in regard to quaternium 15 and thimerosal may be related to their smaller concentration in this study as compared to the GBEDC study: quaternium15, 0.5% in this study versus 1.0% in the GBEDC study and thimerosal, 0.05% in this study versus 0.1% in the GBEDC study. Although the Brazilian Standard screenings of these studies were composed of the same substances, the concentration of these two allergens were different.
About the Cosmetic Series, the most frequent allergen was tosylamide formaldehyde resin (10.4%). Duarte et al reported the rate of 12.7% to this allergen in an adolescent group of patients. 3 Artus et al reported data from 133 patients: mean age 42 years; 69.2% female. The most frequent allergens: nickel, thimerosal, p-phenylenediamine, neomycin, cobalt chloride, PPD mix, potassium dichromate. 4 Comparing with the NACDG (North American Contact Dermatitis Group) data we may observe that nine of the 12 most frequent allergens of this study are among the 12 most frequent allergens in this American study. Quaternium 15 was placed in the fourth position in the NACDG study but was tested at 2.0%, unlike the 0.5% in our study. 5 Belsito recommended the removal of thimerosal from NACDG Screening because of its usual irrelevance.
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Comparing to the European data, concerning the 12 most frequent allergens of both ours and European studies, eight allergens are common.
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Thimerosal was not tested in either the American or European studies. 5, 7 There were no significant differences in patch tests results in atopics and non atopics in this study (p>0.05). The hands are the most common dermatitis site in both this and GBEDC studies. Limitations of this study: during this study period there was a change in the position of the substances in the Standard Series (enabling bias) after the studies reported by Duarte et al, allowing for significant advance in the battery. 8, 9 Selected patient population. Differences in concentration and number make comparison difficult. 2, 5, 7 Advantages: the same dermatologist did all the readings and interpretations; same manufacturer of the test material; same substances concentration. q 
